SCI
DXCM icon

Stableford Capital II’s DexCom DXCM Stock Holding History

Stableford Capital II’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,477
Closed -$1.2M – 121
2024
Q4 		$1.2M Buy
15,477
+10,874
+236% +$805K 0.48% 55
2024
Q3 		$319K Buy
4,603
+11
+0.2% +$903 0.13% 119
2024
Q2 		$526K Buy
4,592
+212
+5% +$26.8K 0.21% 113
2024
Q1 		$608K Buy
4,380
+13
+0.3% +$1.63K 0.24% 101
2023
Q4 		$563K Buy
4,367
+88
+2% +$8.99K 0.24% 95
2023
Q3 		$347K Buy
4,279
+1
+0% +$113 0.16% 96
2023
Q2 		$485K Buy
+4,278
New +$517K 0.21% 88
2023
Q1 		– Sell
-4,052
Closed -$446K – 92
2022
Q4 		$446K Buy
+4,052
New +$445K 0.24% 89

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Stableford Capital II's DXCM Position: Q1 2025 in Review

Stableford Capital II sold out of DexCom (DXCM) in Q1 2025, closing a stake of 15,477 shares — an estimated $1.2M sold.

Stableford Capital II first reported a position in DXCM in Q4 2022 and held it in 8 quarters. The position peaked at $1.2M in Q4 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Stableford Capital II reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Stableford Capital II sold 15,477 DexCom shares in Q1 2025, an estimated $1.2M.
  • Stableford Capital II first reported a position in DexCom in Q4 2022 and held it in 8 quarters.
  • Stableford Capital II's DexCom position peaked at $1.2M in Q4 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Stableford Capital II's 13F filing for Q1 2025, filed 21 Apr 2025.